News Archive

2020

December

Media Release / Dec 15, 2020

Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF

Read More
Media Release / Dec 09, 2020

Novartis Kisqali® demonstrates nearly five years median overall survival in metastatic breast cancer

Read More
Media Release / Dec 08, 2020

Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif®* in chronic myeloid leukemia trial

Read More
Media Release / Dec 07, 2020

Novartis and Amgen partner with Karamo Brown to support and empower people living with migraine

Read More
Media Release / Dec 01, 2020

Novartis announces FDA approval of Xolair® (omalizumab) for adults with nasal polyps

Read More

November

Media Release / Nov 19, 2020

New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases

Read More
Media Release / Nov 13, 2020

New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17, regardless of age and gender

Read More
Media Release / Nov 05, 2020

Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study

Read More

October

Media Release / Oct 05, 2020

Novartis STEP Program™ awards nearly $375,000 to patient advocacy organizations for their innovative solutions in biomarker testing; now accepting proposals for caregiving in cancer and certain blood disorders

Read More
Media Release / Oct 03, 2020

Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine

Read More

Related Links